Related Experiment Video
Updated: Jul 18, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
A Rare Case Report of Acquired Coagulation Factor XI Deficiency
Background:
Acquired coagulation factor deficiency is an autoimmune hemorrhagic disease caused by the production of antibodies to coagulation factor. The incidence of acquired coagulation factor XI deficiency is low and rarely reported.
Case Presentation:
We report a case of a patient with acquired coagulation factor XI deficiency. The patient was a 24-year-old female who presented with mild yellowing of the skin, general malaise, palpitation, and no obvious bleeding symptoms prior to admission, such as skin and mucous membrane petechiae. She was initially diagnosed with anemia because her hemoglobin was 62 g/L. Laboratory results showed activated partial thromboplastin time (APTT) prolonged with a test value of 83.40 seconds and could not be corrected by corrective experiments; Factor XI activity was less than 0.1%, positive for factor XI antibody, and a plasma coagulation factor XI inhibitor was 35.20 BU/mL. She was eventually diagnosed with acquired coagulation factor XI deficiency, Plasmapheresis were performed to clear antibodies, and patient's condition improved.
Conclusions:
Plasmapheresis played a positive role in the treatment of acquired factor XI deficiency. Clear early diagnosis and proper treatment can help to improve the cure rate of patients.
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

